Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sisram MedicalSRAMF 64 EV-to-OCF is 14.32 as of Aug. 11, 2026, which is 67% above its 10-year median of 8.55. GuruFocus rates SRAMF with a GF Score™ of 64/100 and a GF Value™ of $0.93 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Sisram Medical ranks worse than 64.71% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Sisram Medical's Enterprise Value is $134.6 Mil.
Sisram Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $9.4 Mil. Therefore, Sisram Medical's EV-to-OCF for today is 14.32.
The historical rank and industry rank for Sisram Medical's EV-to-OCF or its related term are showing as below:
SRAMF'
s EV-to-OCF Range Over the Past 10 Years
Min: 1.33 Med: 8.55 Max: 61.85
Current: 14.34
During the past 12 years, the highest EV-to-OCF of Sisram Medical was 61.85. The lowest was 1.33. And the median was 8.55.
SRAMF's EV-to-OCF is ranked worse than 64.71% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.85
vs SRAMF: 14.34
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sisram Medical (OTCPK:SRAMF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sisram Medical's PE Ratio (TTM) for today is calculated as:
Sisram Medical's share price for today is $0.43835.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.041.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sisram Medical EV-to-OCF Related Terms
Sisram Medical EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Sisram Medical's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sisram Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sisram Medical EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Sisram Medical's EV-to-OCF falls into.
Sisram Medical's current Enterprise Value is $134.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $9.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sisram Medical (SRAMF) has a EV-to-OCF of 14.32 as of Aug. 11, 2026. This is 67% above median its historical median of 8.55. Over the past decade, Sisram Medical's EV-to-OCF has ranged from 1.33 to 61.85. According to the industry distribution chart, Sisram Medical ranks #552 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 64.7%.
Is Sisram Medical's EV-to-OCF too high?
Sisram Medical's current EV-to-OCF of 14.32 is 67% above median its 10-year median of 8.55. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 61.85. The Medical Devices & Instruments industry median EV-to-OCF is 7.85. Sisram Medical's value of 14.32 is 82.4% above this industry median. Based on the distribution chart, Sisram Medical ranks #552 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sisram Medical has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #552 out of 853 companies for EV-to-OCF. This places Sisram Medical in the lower half of its industry. The industry median EV-to-OCF is 7.85. Sisram Medical's value of 14.32 is 82.4% above this benchmark. Historically, Sisram Medical's own EV-to-OCF has ranged from 1.33 to 61.85 over the past decade. While the company's 10-year median is 8.55 vs. the industry median of 7.85, Sisram Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.85, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current EV-to-OCF of 14.32 is 82.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current EV-to-OCF is 14.32, which is 67% above median its own 10-year median of 8.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.93, compared to a current price of $0.44 — trading 52.9% below its estimated fair value. The current EV-to-OCF is 14.32, which is 67% above median its 10-year median of 8.55 and 82.4% above the Medical Devices & Instruments industry median of 7.85. Sisram Medical's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current EV-to-OCF is 14.32 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sisram Medical (SRAMF) Overvalued in 2026?
Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued.
The current stock price of $0.44 is trading 52.9% below its estimated GF Value™ of $0.93.
GuruFocus considers Sisram Medical to be Significantly Undervalued.
Key valuation signals for SRAMF:
EV-to-OCF: 14.32 (67% above median its 10-year median of 8.55)
GF Value™: $0.93 vs. price of $0.44 (52.9% below fair value)
Industry Position: 82.4% above the Medical Devices & Instruments median (#552 of 853)
No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
64GF Score
Get the complete analysis for SRAMF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRAMF has been successfully added to your 
